dc.contributor.author |
Wong, Aaron BC |
en |
dc.contributor.author |
Wang, Michael |
en |
dc.contributor.author |
Liu, Kevin |
en |
dc.contributor.author |
Prime, Zak J |
en |
dc.contributor.author |
Danesh-Meyer, Helen |
en |
dc.contributor.author |
Craig, Jennifer |
en |
dc.date.accessioned |
2018-10-17T01:57:46Z |
en |
dc.date.issued |
2018-07 |
en |
dc.identifier.issn |
1542-0124 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/42467 |
en |
dc.description.abstract |
PURPOSE:To assess tear film parameters, ocular surface characteristics, and dry eye symptomology in patients receiving topical anti-glaucoma medications. METHODS:Thirty-three patients with a diagnosis of open angle glaucoma or ocular hypertension, receiving unilateral topical anti-glaucoma medication for at least 6 months, were recruited in a cross-sectional, investigator-masked, paired-eye comparison study. Tear film parameters, ocular surface characteristics, and dry eye symptomology of treated and fellow eyes were evaluated and compared. RESULTS:The mean ± SD age of the participants was 67 ± 12 years, and the mean ± SD treatment duration was 5.3 ± 4.4 years. Treated eyes had poorer non-invasive tear film breakup time (p = 0.03), tear film osmolarity (p = 0.04), bulbar conjunctival hyperaemia (p = 0.04), eyelid margin abnormality grade (p = 0.01), tear meniscus height (p = 0.03), and anaesthetised Schirmer value (p = 0.04) than fellow eyes. There were no significant differences in dry eye symptomology, meibomian gland assessments, and ocular surface staining between treated and fellow eyes (all p > 0.05). CONCLUSIONS:Adverse changes in tear film stability, tear osmolarity, conjunctival hyperaemia, and eyelid margins were observed in treated eyes. This suggests that inflammatory mechanisms may be implicated in the development of dry eye in patients receiving long term topical anti-glaucoma therapy. |
en |
dc.format.medium |
Print-Electronic |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
The ocular surface |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Conjunctiva |
en |
dc.subject |
Meibomian Glands |
en |
dc.subject |
Tears |
en |
dc.subject |
Humans |
en |
dc.subject |
Dry Eye Syndromes |
en |
dc.subject |
Glaucoma |
en |
dc.subject |
Antihypertensive Agents |
en |
dc.subject |
Cross-Sectional Studies |
en |
dc.subject |
Adult |
en |
dc.subject |
Aged |
en |
dc.subject |
Aged, 80 and over |
en |
dc.subject |
Middle Aged |
en |
dc.subject |
Female |
en |
dc.subject |
Male |
en |
dc.title |
Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1016/j.jtos.2018.03.002 |
en |
pubs.issue |
3 |
en |
pubs.begin-page |
289 |
en |
pubs.volume |
16 |
en |
dc.rights.holder |
Copyright: The author |
en |
dc.identifier.pmid |
29510226 |
en |
pubs.end-page |
293 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Journal Article |
en |
pubs.elements-id |
732168 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Ophthalmology Department |
en |
dc.identifier.eissn |
1937-5913 |
en |
pubs.record-created-at-source-date |
2018-03-07 |
en |
pubs.dimensions-id |
29510226 |
en |